Contents

Search


creatine kinase MM in blood; GSP Neonatal Creatine Kinase-MM kit

Indications: - screening newborns for Duchenne muscular dystrophy Clinical significance: - elevated levels may be asssociated with Duchenne muscular dystrophy Methods: - electrophoresis (presumptive) Specimen: - heel stick collected 24 to 48 hours after birth.

Related

creatine kinase MM

General

neonatal screening creatine kinase (CK) in blood creatine kinase (CK) MM in body fluid

References

  1. FDA News Release. December 12, 2019 FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-test-aid-newborn-screening-duchenne-muscular-dystrophy